AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17508190 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30
Study 17508190 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30
Study 17508190 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30
Study 17508190 — intervention group
Group type: COMPARATOR
Intervention: 10 mg vs 12.5 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30
Study 16371677 — intervention group
Group type: EXPERIMENTAL
Intervention: Schoolwide intervention that incorporated universal and targeted treatment
Number of subjects: 4
Study 16371677 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted-school intervention delivered to individual students
Number of subjects: 4
Study 16371677 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted-home intervention delivered in home and regular classroom settings
Number of subjects: 4
Study 16371677 — intervention group
Group type: COMPARATOR
Intervention: Control condition that did not receive a designated intervention
Number of subjects: 4
Study 12215004 — intervention group
Group type: EXPERIMENTAL
Intervention: Group session with a Filipino health educator discussing health benefits of exercise
Number of subjects: 530
Study 12215004 — intervention group
Group type: COMPARATOR
Intervention: Group session with a Filipino health educator discussing breast and cervical cancer screening
Number of subjects: 530
Study 10205469 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal Resuscitation Program (NRP)
Number of subjects: 102
Study 8555131 — intervention group
Group type: EXPERIMENTAL
Intervention: One single pre‐operative dose of metronidazole (10 mg/kg)
Number of subjects: 544
Study 8555131 — intervention group
Group type: EXPERIMENTAL
Intervention: Both metronidazole (20 mg/kg) and cefuroxime (50 mg/kg) in a single preoperative dose
Number of subjects: 544
Study 8555131 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 544
Study 8555131 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics (metronidazole and cefuroxime)
Number of subjects: 544
Study 8555131 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotics
Number of subjects: 544
Study 1975490 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with morphine sulfate
Number of subjects: 83
Study 1975490 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine injections as needed
Number of subjects: 83
Study 7150 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallamine triethiodide (40 mg)
Number of subjects: 20
Study 7150 — intervention group
Group type: COMPARATOR
Intervention: Control group (no muscle relaxant)
Number of subjects: 20
Study 31869726 — intervention group
Group type: EXPERIMENTAL
Intervention: G1: 24 sets of five repetitions with 30 s rest at 80% of one repetition maximum using Iowa Oral Performance Instrument (IOPI) per day
Number of subjects: 31
Study 31869726 — intervention group
Group type: EXPERIMENTAL
Intervention: G2: Forceful swallow of 5 mL of water in a neutral posture every 10 s for 20 min per day
Number of subjects: 31
Study 31869726 — intervention group
Group type: EXPERIMENTAL
Intervention: G3: 5 mL of water swallowing exercise in chin-down posture every 10 s for 20 min per day
Number of subjects: 31
Study 30710323 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive radiochemotherapy (RCT)
Number of subjects: 169
Study 26313129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 0
Study 26075813 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 93
Study 26075813 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT
Number of subjects: 93
Study 23216622 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 21
Study 23216622 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IVIG)
Number of subjects: 21
Study 23216622 — intervention group
Group type: COMPARATOR
Intervention: Historical control (untreated patients)
Number of subjects: 21
Study 21778216 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) for 6 months
Number of subjects: 48
Study 19335744 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitaxsentan
Number of subjects: 229
Study 19335744 — intervention group
Group type: COMPARATOR
Intervention: Bosentan
Number of subjects: 229
Study 17891897 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 200 mg administered at specified times during Days 2-4
Number of subjects: 20
Study 17891897 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 200 mg
Number of subjects: 20
Study 17891897 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 20
Study 14718884 — intervention group
Group type: EXPERIMENTAL
Intervention: Test tooth (maxillary first premolar subjected to orthodontic force)
Number of subjects: 17
Study 14718884 — intervention group
Group type: COMPARATOR
Intervention: Control tooth (contralateral first premolar not subjected to mechanical stress)
Number of subjects: 17
Study 11161370 — intervention group
Group type: EXPERIMENTAL
Intervention: DepoCyte 50 mg injected once every 2 weeks for one month of induction therapy
Number of subjects: 43
Study 11161370 — intervention group
Group type: EXPERIMENTAL
Intervention: DepoCyte 50 mg
Number of subjects: 43
Study 9002389 — intervention group
Group type: EXPERIMENTAL
Intervention: White light treatment for 2 weeks
Number of subjects: 30
Study 9002389 — intervention group
Group type: COMPARATOR
Intervention: Placebo red light treatment for 2 weeks
Number of subjects: 30
Study 9002389 — intervention group
Group type: EXPERIMENTAL
Intervention: Summer performance assessment
Number of subjects: 30
Study 7989947 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb-salvage surgery
Number of subjects: 348
Study 7989947 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide amputations
Number of subjects: 348
Study 7989947 — intervention group
Group type: COMPARATOR
Intervention: Radical amputation
Number of subjects: 348
Study 7989947 — intervention group
Group type: COMPARATOR
Intervention: Rotationplasty
Number of subjects: 348
Study 7989947 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy response
Number of subjects: 348
Study 7989947 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical margins
Number of subjects: 348
Study 7989947 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 348
Study 2464104 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (20 mg)
Number of subjects: 8
Study 2464104 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 8
Study 2464104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 28544687 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps isometric contraction exercise
Number of subjects: 250
Study 28544687 — intervention group
Group type: COMPARATOR
Intervention: Local physiotherapy and oral nonsteroidal anti‐inflammatory drugs
Number of subjects: 250
Study 27869712 — intervention group
Group type: EXPERIMENTAL
Intervention: Pterocarpan-high soybean leaf extract (PT) 2 g/day for 12 weeks
Number of subjects: 0
Study 27869712 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch, 3 g/day) for 12 weeks
Number of subjects: 0
Study 24964508 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple myeloma (MM) patients
Number of subjects: 21
Study 24964508 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple myeloma IgG group
Number of subjects: 21
Study 24964508 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (controls)
Number of subjects: 21
Study 22514205 — intervention group
Group type: EXPERIMENTAL
Intervention: FES-cycling
Number of subjects: 35
Study 22514205 — intervention group
Group type: COMPARATOR
Intervention: Placebo FES-cycling
Number of subjects: 35
Study 20679774 — intervention group
Group type: EXPERIMENTAL
Intervention: L-BIS group (BIS values 20-30)
Number of subjects: 70
Study 20679774 — intervention group
Group type: COMPARATOR
Intervention: H-BIS group (BIS values 50-60)
Number of subjects: 70
Study 20679774 — intervention group
Group type: EXPERIMENTAL
Intervention: L-BIS group
Number of subjects: 70
Study 20679774 — intervention group
Group type: COMPARATOR
Intervention: H-BIS group
Number of subjects: 70
Study 20679774 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study 18423987 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 555
Study 18423987 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 555
Study 16052084 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose nevirapine (NVP)
Number of subjects: 1051
Study 16052084 — intervention group
Group type: COMPARATOR
Intervention: 6 weeks of zidovudine (ZDV)
Number of subjects: 1051
Study 16052084 — intervention group
Group type: COMPARATOR
Intervention: NVP and ZDV (comparison)
Number of subjects: 1051
Study 16052084 — intervention group
Group type: COMPARATOR
Intervention: ZDV use
Number of subjects: 1051
Study 16052084 — intervention group
Group type: COMPARATOR
Intervention: Maternal CD4 cell count < 500 x 10(6) cells/l
Number of subjects: 1051
Study 16052084 — intervention group
Group type: COMPARATOR
Intervention: Maternal viral load > 50 000 copies/ml
Number of subjects: 1051
Study 16052084 — intervention group
Group type: COMPARATOR
Intervention: Breastfeeding
Number of subjects: 1051
Study 11840370 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary blood glucose (BG) measurements
Number of subjects: 23
Study 10460925 — intervention group
Group type: EXPERIMENTAL
Intervention: Parapertussis
Number of subjects: 81
Study 10460925 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertussis
Number of subjects: 81
Study 7488480 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 51
Study 7488480 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% nitrous oxide in oxygen
Number of subjects: 51
Study 7488480 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% oxygen in nitrogen
Number of subjects: 51
Study 2021986 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural nalbuphine (0.075-0.3 mg.kg-1)
Number of subjects: 0
Study 2021986 — intervention group
Group type: COMPARATOR
Intervention: Epidural morphine (0.1 mg.kg-1)
Number of subjects: 0
Study 6177846 — intervention group
Group type: EXPERIMENTAL
Intervention: Naldecon (antihistamine-decongestant)
Number of subjects: 53
Study 6177846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 30231750 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile priming with attachment security visualization tasks over a 7-day period
Number of subjects: 112
Study 30231750 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who reported less effort and more pleasure in visualization tasks
Number of subjects: 112
Study 30120446 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard first intervention (less frequent, atelic, phonologically complex verbs)
Number of subjects: 20
Study 30120446 — intervention group
Group type: COMPARATOR
Intervention: Easy first intervention (highly frequent, telic, phonologically simple verbs)
Number of subjects: 20
Study 26735993 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG
Number of subjects: 168
Study 26735993 — intervention group
Group type: COMPARATOR
Intervention: Non-ATG
Number of subjects: 168
Study 25233654 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire needling therapy
Number of subjects: 60
Study 25233654 — intervention group
Group type: COMPARATOR
Intervention: Oxycycline tablets (100 mg, twice daily for 20 days) with external application of adapalene gel before sleep
Number of subjects: 60
Study 25233654 — intervention group
Group type: COMPARATOR
Intervention: Oxycycline tablets
Number of subjects: 60
Study 22608570 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (OCSs), more than 2 courses per year
Number of subjects: 780
Study 22608570 — intervention group
Group type: COMPARATOR
Intervention: Oral corticosteroids (OCSs), less than or equal to 2 courses per year
Number of subjects: 780
Study 22608570 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (OCSs)
Number of subjects: 780
Study 20807066 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose, immediate-release dexmethylphenidate (dMPH)
Number of subjects: 10
Study 20807066 — intervention group
Group type: COMPARATOR
Intervention: No medication
Number of subjects: 10
Study 17925654 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 3 day catheter exchange (q3day)
Number of subjects: 196
Study 17925654 — intervention group
Group type: COMPARATOR
Intervention: Every 4 day catheter exchange (q4day)
Number of subjects: 196
Study 16722590 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery (RA) grafts
Number of subjects: 52
Study 16722590 — intervention group
Group type: COMPARATOR
Intervention: Long saphenous vein (LSV) grafts
Number of subjects: 52
Study 12637133 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic dosing (n=43)
Number of subjects: 81
Study 12637133 — intervention group
Group type: COMPARATOR
Intervention: Fixed once‐daily dosing (n=38)
Number of subjects: 81
Study 10982163 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplement alone (750 mg daily)
Number of subjects: 53
Study 10982163 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate plus calcitriol (750 mg calcium carbonate + 0.5 microg calcitriol daily)
Number of subjects: 53
Study 10982163 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (calcium alone and calcium plus calcitriol)
Number of subjects: 53
Study 9208534 — intervention group
Group type: EXPERIMENTAL
Intervention: Shengmaisan (SMS)
Number of subjects: 62
Study 9208534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 1480877 — intervention group
Group type: EXPERIMENTAL
Intervention: Test drug given once daily
Number of subjects: 35
Study 1480877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 6198064 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cisplatin (120 mg/m2, monthly) combined with vinblastine and bleomycin
Number of subjects: 114
Study 6198064 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cisplatin (15 mg/m2, daily X 5 monthly) combined with vinblastine and bleomycin
Number of subjects: 114
Study 30994898 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Care Improvement (QCI) intervention
Number of subjects: 29346
Study 30994898 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 29346
Study 29432613 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline TRAIL
Number of subjects: 103
Study 29432613 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Dkk1
Number of subjects: 103
Study 29432613 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CTX-1
Number of subjects: 103
Study 27427235 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogens (CEE) daily for 28 days
Number of subjects: 64
Study 27427235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 24529546 — intervention group
Group type: EXPERIMENTAL
Intervention: VALOR II
Number of subjects: 223
Study 24529546 — intervention group
Group type: COMPARATOR
Intervention: VALOR
Number of subjects: 223
Study 24529546 — intervention group
Group type: EXPERIMENTAL
Intervention: VALOR test arm
Number of subjects: 223
Study 22327404 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid/heparin emulsion (Intralipid) infusion
Number of subjects: 10
Study 22327404 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study 22327404 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin only infusion
Number of subjects: 10
Study 20192907 — intervention group
Group type: EXPERIMENTAL
Intervention: t'ai chi program
Number of subjects: 82
Study 20192907 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 17326908 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway (PLMA)
Number of subjects: 50
Study 17326908 — intervention group
Group type: COMPARATOR
Intervention: Standard laryngeal mask airway (SLMA)
Number of subjects: 50
Study 16139778 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored behavioral medicine intervention
Number of subjects: 122
Study 16139778 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise therapy
Number of subjects: 122
Study 11966744 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 IU recFSH
Number of subjects: 36
Study 11966744 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU recFSH
Number of subjects: 36
Study 11966744 — intervention group
Group type: EXPERIMENTAL
Intervention: 225 IU recFSH
Number of subjects: 36
Study 11966744 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU uFSH
Number of subjects: 36
Study 11966744 — intervention group
Group type: COMPARATOR
Intervention: Lyndiol (2.5 mg lynestrenol + 0.05 mg ethinyl‐oestradiol)
Number of subjects: 36
Study 11966744 — intervention group
Group type: COMPARATOR
Intervention: Pill-free period
Number of subjects: 36
Study 11966744 — intervention group
Group type: COMPARATOR
Intervention: Lyndiol
Number of subjects: 36
Study 10409137 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training and multinutrient supplementation
Number of subjects: 26
Study 10409137 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 26
Study 7558212 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraumbilical oxytocin (10 units in 20 ml saline)
Number of subjects: 100
Study 7558212 — intervention group
Group type: COMPARATOR
Intervention: Control group (oxytocin infusion 10 units in 250 ml of dextrose saline at 125 ml/hr)
Number of subjects: 100
Study 2288128 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery combined with preoperative Co 60 gamma teletherapy (139 cases)
Number of subjects: 281
Study 2288128 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (142 cases)
Number of subjects: 281
Study 2288128 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative Co 60 gamma teletherapy (part of combined treatment)
Number of subjects: 281
Study 6789851 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate dry powder inhalation (20 mg/dose)
Number of subjects: 29
Study 6789851 — intervention group
Group type: COMPARATOR
Intervention: Metered dose aerosol (2 mg/dose)
Number of subjects: 29
Study 30721793 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclin D1 overexpression
Number of subjects: 54
Study 28714728 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus contingency management (CM)
Number of subjects: 0
Study 28714728 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) plus no CM
Number of subjects: 0
Study 28714728 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 0
Study 28714728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25856757 — intervention group
Group type: EXPERIMENTAL
Intervention: THA physiotherapy care protocol (THAPCP)
Number of subjects: 106
Study 25856757 — intervention group
Group type: COMPARATOR
Intervention: THA protocol (THAP)
Number of subjects: 106
Study 23267373 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (turbinoplasty with functional endoscopic sinus surgery)
Number of subjects: 44
Study 23267373 — intervention group
Group type: COMPARATOR
Intervention: Medical intervention (fluticason nasal spray and oral Pseudoephedrin)
Number of subjects: 44
Study 19200398 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Ribose
Number of subjects: 26
Study 19200398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 17403076 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg (PPI group)
Number of subjects: 143
Study 17403076 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 800 mg (H2RA group)
Number of subjects: 143
Study 15110132 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg) once daily for 7 days
Number of subjects: 62
Study 15110132 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (75 mg) once daily for 7 days
Number of subjects: 62
Study 15110132 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam (7.5 mg) once daily for 7 days
Number of subjects: 62
Study 15110132 — intervention group
Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 62
Study 11673199 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micron/d of HFA-134a beclomethasone dipropionate
Number of subjects: 12
Study 11673199 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 micron/d of HFA-134a beclomethasone dipropionate
Number of subjects: 12
Study 9855324 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg once/day for 14 days
Number of subjects: 216
Study 9855324 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin 500 mg twice/day for 14 days
Number of subjects: 216
Study 8050421 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 14
Study 8050421 — intervention group
Group type: COMPARATOR
Intervention: Lumbar epidural anaesthesia
Number of subjects: 14
Study 8050421 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study 8050421 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 14
Study 3184885 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana-laced brownies (1.6 g of marijuana plant material, 2.8% THC)
Number of subjects: 5
Study 3184885 — intervention group
Group type: COMPARATOR
Intervention: Placebo brownies (0% THC)
Number of subjects: 5
Study 30287202 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied to extraction sockets (group A)
Number of subjects: 30
Study 30287202 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B) - sockets closed without PRF
Number of subjects: 30
Study 28588109 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression (ASD)
Number of subjects: 210
Study 28588109 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic arthroscopy (DA)
Number of subjects: 210
Study 28588109 — intervention group
Group type: COMPARATOR
Intervention: Supervised progressive exercise therapy (ET)
Number of subjects: 210